Lo, Chung Mau

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice

Ye, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 206

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice

Ye, D., Wang, Y., Li, H., Jia, W., Man, K., Lo, C. M., Wang, Y., Lam, K. S. L., & Xu, A. (2014) · Hepatology

Drug-Induced Hepatotoxicity and ProtectionFibroblast Growth Factor Research

Cited by 184

Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway

Shao, Y., Lo, C. M., Ling, C. C., Liu, X. B., Ng, K. T.-P., Chu, A. C. Y., Ma, Y. Y., Li, C. X., Fan, S. T., & Man, K. (2014) · Cancer Letters

T-cell and B-cell ImmunologyHepatocellular Carcinoma Treatment and Prognosis

Cited by 158

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

Wong, J. S. L., Kwok, G. G. W., Tang, V., Li, B. C. W., Leung, R., Chiu, J., Ma, K. W., She, W. H., Tsang, J., Lo, C. M., et al. (2021) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 142

Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma

Ng, K. T.-P., Pang, L., Wang, J.-Q., She, W. H., Tsang, S. H.-Y., Lo, C. M., Man, K., & Cheung, T. T. (2024) · Hepatobiliary & Pancreatic Diseases International

Hepatocellular Carcinoma Treatment and PrognosisCancer, Stress, Anesthesia, and Immune Response

Cited by 5